Lab Information

Giada Sebastiani (MD)

Senior Scientist
Centre for Outcomes Research and Evaluation
Department of Medicine (McGill)

Research Profile

 Fundamental: 20%
 Clinical: 50%
 Epidemiology: 30%
 Evaluation: 0%
 This email address is being protected from spambots. You need JavaScript enabled to view it.

Keywords

Fatty liver • serum liver biomarkers • elastography • HIV • hepatitis C • hepatitis B

Research Interests

My research focuses on screening for liver fibrosis and fatty liver of at-risk populations, including HIV+ patients, patients with diabetes and obesity, women with polycystic ovary syndrome, and patients with inflammatory bowel syndrome. To conduct these studies, I employ serum fibrosis biomarkers and a non-invasive machine, which is ultrasound-based, named Fibroscan. I am also site investigator of multiple global clinical trials for antifibrotic compounds in NASH.


Team Members

Name Position

Latest Publications

  1. Zhou, X.-D., Huang, D. Q., Sebastiani, G. & Zheng, M.-H. (2026). The Changing Etiological Landscape of Liver Cancer in the Era of Metabolic Disease. Liver international : official journal of the International Association for the Study of the Liver, vol. 46, p. e70781.
  2. Pugliese, N., White, T. M., Brennan, P. N., Pannain, S., Hagström, H., Michel, M., Rice-Duek, L., Targher, G., Caussy, C., Dillon, J. F., Tacke, F., Kopka, C. J., Sebastiani, G., Boursier, J., Tsochatzis, E. A., Brouwer, W. P., Guaraldi, G., Vettor, R., Thiele, M., Roden, M., Stefan, N., Jarvis, H., Gines, P., Schattenberg, J. M., Pose, E., Buttigieg, S., Byrne, C. D. & Lazarus, J. V. (2026). Diagnostic innovation and models of care to improve fibrosis detection and risk stratification in steatotic liver disease. The Lancet regional health. Europe, vol. 65, p. 101722.
  3. White, T. M., Sebastiani, G., Guaraldi, G., Pericàs, J. M., Fuster-Ruizdeapodaca, M. J. & Lazarus, J. V. (2026). A people-first, systems-oriented approach to liver disease in HIV infection. Nature reviews. Gastroenterology & hepatology, vol. 23, p. 600-601.
  4. Cinque, F., Nudo, M., Saeed, S., Lim, J., Kablawi, D., Mariano, G., Lupu, A., Elgretli, W., Moodie, E. E. M., Price, C., Monteith, K., Cooper, C., Walmsley, S., Kronfli, N., Cox, J., Costiniuk, C., De Pokomandy, A., Routy, J.-P., Klein, M. B., Lebouche, B. & Sebastiani, G. (2026). Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated With Impaired Health-Related Quality of Life in People With HIV. Gastro hep advances, vol. 5, p. 100966.
  5. Lei, S.-Y., Han, Y., Rockey, D. C., Alswat, K., Wong, V.-W., Jumaev, N., Toro-Huamanchumo, C. J., Taha, S., El-Kassas, M., George, J., Muthiah, M., Ghanem, O., Yoneda, M., Hang, D. V., Sebastiani, G., Papatheodoridis, G., Abu-Abeid, A., Robertson, A. G., Kim, S. H., Weiner, R., Mahawar, K., Shabbir, A., Kermansaravi, M., Rajan, R., Seki, Y., Taskin, H. E., Shikora, S., Oliveros, E., Parmar, C., Cheng, Q., Thaher, O., Ruiz-Úcar, E., Oviedo, R., Ribeiro, R., Musella, M., Ramos, A. C., Ryu, S.-W., Abdelbaki, T., Lee, W. J., Chan, M. P., Garcia Flores, J. E., Skinovsky, J., Madkhali, A., Weiner, S., Tacke, F., Yang, W., Neuberger, J., Zheng, M.-H. & International Obesity Society Working Group on Steatotic Liver Disease (2026). An international multidisciplinary consensus statement on laparoscopic liver biopsy. Cell reports. Medicine, vol. 7, p. 102831.
  6. Farhat, R., Zamora-Medina, M. D. C., Bae, S.-C., Barber, M. R. W., Clarke, A. E., Fortin, P. R., Touma, Z., Laskin, C. A., Malhamé, I., Sebastiani, G., Peschken, C., Ugarte-Gil, M. F., Legge, A., Bernatsky, S. & Vinet, É. (2026). Increased Risk of Intrahepatic Cholestasis of Pregnancy in Women With Systemic Lupus Erythematosus Exposed to Azathioprine. Arthritis & rheumatology (Hoboken, N.J.).
  7. Cinque, F., Saeed, S., Farina, F., Kablawi, D., Lim, J., Cascio, A., Gioè, C., Tsochatzis, E., Lombardi, R., Cordie, A., Mohamed, R., Kamel, A. M., Esmat, G., Bandera, A., Milic, J., Benke, D., Elamouri, F., Rockstroh, J. K., Guaraldi, G. & Sebastiani, G. (2026). FIB-4 fails to identify significant liver fibrosis in people with HIV: A large multinational screening study. Hepatology (Baltimore, Md.).
  8. Burnside, J., Djerboua, M., Flemming, J. A., Sebastiani, G., Wong, W. W. L., Lu, Z., Bajaj, H. S., Patel, K., Biondi, M., Betel, M., Nahwegahbow, A., Greenwald, Z. R., Moodie, E. E. M. & Saeed, S. (2026). Reimbursement restrictions reduce liver fibrosis screening in adults with diabetes in Ontario: a population-based interrupted time series analysis. Scientific reports, vol. 16.
  9. Yoon, S. Y., El Bouzaidi Tiali, S., Wing, S., Davalan, W., Jatana, S., Slapcoff, L., Nitulescu, R., Rahme, E., Nakhla, M., Morin, S. N., Sebastiani, G. & Sapir-Pichhadze, R. (2026). Metabolic Dysfunction-Associated Steatotic Liver Disease and Kidney Transplant Outcomes. Kidney international reports, vol. 11, p. 106477.
  10. Zhou, X.-D., Sebastiani, G. & Zheng, M.-H. (2026). Reply to: "Hypertension and long-term adverse clinical outcomes in MASLD: Sensitivity analyses for unmeasured or uncontrolled confounding". Journal of hepatology, vol. 85, p. e24-e25.
More on PubMed 



See also

Card image
Bertrand
Lebouché


See profile
Card image
Marina
Klein


See profile
Card image
Joseph
Cox


See profile
Card image
Nadine
Kronfli


See profile
Card image
Philip
Wong


See profile
Card image
Jean-Pierre
Routy


See profile